Loading...
The use of PEGylated liposomes in the development of drug delivery applications for the treatment of hemophilia
Hemophilia A is a rare X-linked bleeding disorder caused by lack or dysfunction of coagulation factor VIII (FVIII). Hemophilia A is treated with replacement therapy, but frequent injections of the missing FVIII often lead to the formation of inhibitory antibodies. Patients who develop high levels of...
Na minha lista:
| Main Authors: | , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Dove Medical Press
2010
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2939703/ https://ncbi.nlm.nih.gov/pubmed/20856833 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|